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Supplementary Fig. 1 | Type I IFN does not affect phagocytosis or acidification. Number of internalized Δhly Lm 
(a) and E. coli (b) in BMDMs untreated (UT) or treated with IFNβ were enumerated over a 30 min time course. 
Differential antibody staining was carried out to determine the population of intracellular versus extracellular bacteria. 
Phagosome (c) and lysosome (d) acidification in BMDMs treated with or without IFNβ fed with carboxyfluorescein 
succinimidyl ester (CFSE)-particle (phagosome) or FITC-dextran (lysosome). Fluorescence ratiometric imaging was 
used to determine pH value of phagosomes (over 60 min) and lysosomes (at 60 min) calibrated against a standard 
curve. Solid lines represent nonlinear regression fit of the dashed lines. Data shown are means ± standard deviation 
(s.d.) for n = 3 independent experiments. P value was calculated using two-tailed unpaired t-test in (d). ns, not 






Supplementary Fig. 2 | Effect of type I IFN on early phagosome maturation events. a, b, Representative images (a) and 
quantification (b) of Δhly Lm in lysosomes of BMDMs treated with or without IFNβ 4 h post-infection (p.i.) using lysosomal 
marker cresyl violet after 30 min. c, d, Endolysosomal fusion measured in dextran-fed BMDMs treated with or without IFNβ 
using lysosomal marker cresyl violet after 30 min. Representative images (c) and Pearson correlation (d) of colocalization 
between dextran and cresyl violet-positive compartments. e, Phagolysosomal fusion measured using FRET-based assay in 
BMDMs treated with or without IFNβ using particles labeled with donor fluorophore (phagosomes) and acceptor 
fluorophore (lysosomes) over 2 h. Solid lines represent nonlinear regression fit of the dashed lines. f, g, Representative 
images (f) and quantification (g) of phagosomal proteolysis measured using self-quenched substrate DQ-BSA that fluoresces 
in the presence of proteases. E. coli residing in DQ-BSA-positive compartments in BMDMs treated with or without IFNβ 
were enumerated after 4 h. Data shown are means ± s.d. for at least n = 3 independent experiments. P value (b, d, g) was 





Supplementary Fig. 3 | Lm expresses ActA within phagosomes. a, Schematic of GFP reporter fusion construct 
separately integrated in single copy at the tRNAARG locus of WT Lm 10403S strain. PactA promoter with the full-
length actA 5’ untranslated region (UTR) and ribosome binding site (rbs). b, Representative images of the production 
of actA:GFP measured by Western blot in J774 macrophages infected with indicated GFP reporter strains over 4 h. c, 
Representative image of the production of ActA measured by Western blot in BMDMs treated with and without 
bafilomycin A infected with indicated strains 4 h p.i. d-f, Representative images (d) and quantification of ActA-
positive bacteria expressing actA:GFP (e) or actA:GFP-positive bacteria in LAMP1-positive compartments (f) in 
RAW macrophages infected with indicated strains 4 h p.i. Data and images shown are means ± s.d. for at least n = 3 
independent experiments. P value was calculated using one-way ANOVA. ****P < 0.0001. Scale bar, 10 µm. TKO, 





Supplementary Fig. 4 | IFITM3 suppresses LLO degradation in phagosomes. a-c, Representative images (a) and 
quantification of LLO production measured by Western blot in IFITM3 WT and KO BMDMs infected with (b) WT 
Lm or (c) actAplcAplcB Lm over 4 h. Data shown are means ± standard deviation (s.d.) for n = 3 independent 
experiments. P value was calculated using two-way ANOVA. *P = 0.0164, ****P < 0.0001. Source data are provided 





Supplementary Fig. 5 | Effect of IFITM3 on bulk proteolysis and Lm growth in the cytosol. a, b, Bulk proteolysis 
of DQ-BSA-labelled particles in phagosomes treated with IFNβ or IFNγ, in IFITM3 WT and KO BMDMs. Slope of 
the curve’s linear portion in (a) is displayed in (b). c, Growth curve of IFITM3 WT and KO BMDMs infected with 
WT or ΔactA Lm over 12 h. Cells were seeded at sub-confluence density and infected with an MOI of 1. Data shown 
are means ± standard deviation (s.d.) for at least n = 3 independent experiments. P value was calculated using one-
way ANOVA. ****P < 0.0001. 
  



























































































Supplementary Fig. 6 | Type I IFN does not promote Lm cell-to-cell spread in AML12, MEF or Caco2 cells. a-
f, Representative images (a, c, e) and quantification (b, d, f) of an infection focus assay to measure WT Lm cell-to-
cell spread. Indicated cell types were treated with or without IFNβ and infected for 18 h. Dotted lines delineate edge 
of the infection foci. Scale bars, 70 µm. Data shown are means ± s.d. for n = 3 independent experiments. P value was 




























































































Ifnβ F-CCCTATGGAGATGACGGAGA R-CTGTCTGCTGGTGGAGTTCA 
Ifnγr1 F-GTAGCCTCACCGCCTATCAC R-GGGCCTCTCCTGTGAGTCTA 
Tnfα F-CCCATGGATGTCCCATTTAG R-CAATCAGGAGGGTGTGTGTG 
Il4 F-GCCTGCTTTTCACATGAGGT R-AAATATGCGAAGCACCTTGG 
Il10 F-CCAAGCCTTATCGGAAATGA R-TTTTCACAGGGGAGAAATCG 
Il12 F-AGCATAAGAGACGCCCTCAA R-GGTGTTACAGGCCCAAAGAA 
 
Supplementary Table 1 | Summary of primers used to generate Lm strains, and primers used for qPCR. 
 
